Menu Close

COVID-19 linked to increase in biomarkers for abnormal brain proteins

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, led by researchers at Imperial College London and the UK Dementia Research Institute, found that people who had previously had COVID-19 were more likely to have increased levels of biomarkers linked to faulty amyloid proteins—a known hallmark for Alzheimer’s disease.